No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women
Journal of Bone and Mineral Research · 01.10.2023 · 38 (10) · 1415-1421
DOI: 10.1002/jbmr.4887 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Bone and Mineral Research, online erschienen am 01.10.2023. Verfasst von Ian R Reid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Zoledronic Acid, Anti-Inflammatory Agents, Non-Steroidal, Diphosphonates, Bone Diseases, Metabolic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Bisphosphonates are widely used for the prevention and treatment of osteoporosis. Nonsteroidal anti-inflammatory drugs (NSAIDs) are also widely used among the older population group at high risk of fractures. NSAIDs have been shown to impact on bone turnover, and a recent reanalysis of a clinical trial of clodronate found that NSAID use at baseline abrogated any effect of clodronate on either bone density (BMD) or fracture risk. To determine whether NSAIDs influence the efficacy of other bisphosphonates, we have reanalyzed our 6-year randomized controlled trial of zoledronate in 2000 osteopenic postmenopausal women. NSAID use was reported at baseline in 38% of the cohort and anytime use was reported by 65%. The evolution of the zoledronate effects on BMD were almost identical whether or not women were using NSAIDs at baseline and were significant in both subgroups at all BMD sites (p < 0.0001). The significant reduction in the risk of fracture in those allocated to zoledronate (p < 0.0001) showed no interaction with baseline use of NSAIDs (p = 0.33) nor with NSAID use at any time during the study (p = 0.28). The odds of fracture were significantly reduced in both NSAID users and nonusers. We conclude that the present analysis provides no support for the suggestion that NSAIDs interfere with the efficacy of potent bisphosphonates in terms of their effects on bone density or fracture. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Auckland, Auckland, New Zealand.
- Health New Zealand, Auckland, New Zealand.
ORCID-Profile: Ian R Reid
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Reid, I. R., Horne, A. M., Mihov, B., Bastin, S., & Gamble, G. D. (2023). No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women. Journal of Bone and Mineral Research, 38(10), 1415-1421. https://doi.org/10.1002/jbmr.4887
Vancouver
Reid IR, Horne AM, Mihov B, Bastin S, Gamble GD. No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women. Journal of Bone and Mineral Research. 2023;38(10):1415-1421. doi:10.1002/jbmr.4887
BibTeX
@article{Reid2023,
author = {Reid, Ian R and Horne, Anne M and Mihov, Borislav and Bastin, Sonja and Gamble, Gregory D},
title = {No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women},
journal = {Journal of Bone and Mineral Research},
year = {2023},
volume = {38},
number = {10},
pages = {1415--1421},
doi = {10.1002/jbmr.4887}
}
EUVIMED